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Abstract
Background: About 50 % of Thai patients with adult-onset spinocerebellar ataxia (SCA) was Machado-Joseph
disease (MJD), SCA1, SCA2 and SCA6. The author investigated further on less common SCAs in the patients
without any known mutations.
Methods: DNA samples of 82 index patients who were genetically excluded MJD, SCA1, SCA2, SCA6, SCA7
and dentatorubro-pallidoluysian atrophy (DRPLA) were examined. Analysis of SCA8, SCA10, SCA12, SCA17 and SCA19
genes were comprehensively performed. Normal range of trinucleotide repeat expansion sizes of TATA-box-binding
protein gene (TBP) were also determined in 374 control subjects.
Results: Eight patients carried ≥42 CAG/CAA repeat allele in the TBP consistent with SCA17. The pathological repeat
alleles ranged from 42 to 57 repeats. All patients had significant degree of cognitive dysfunction. Other non-ataxic
phenotypes comprised of parkinsonism, chorea, dystonia and myoclonus. A sporadic patient carried a heterozygous
41-repeat allele developed chronic progressive cerebellar degeneration commenced at the age of 28 years. Whilst, 2 %
of the control subjects (8/374) carried the 41-repeat allele. Five of the carriers were re-examined, and revealed that four
of them had parkinsonism and/or cognitive impairment without cerebellar signs. Analysis of other types of SCAs was
all negative.
Conclusions: This is the first study of SCA8, SCA10, SCA12, SCA17 and SCA19 in Thais. SCA17 appears to be
an important cause of ataxia in Thailand. Although, the pathological cut-off point of the TBP repeat allele remains
unclear, the finding suggests that the 41-repeat may be a pathological allele resulting late-onset or mild phenotype.
Apart from ataxia, cognitive impairment and parkinsonism may be clinical presentations in these carriers.
Background
Spinocerebellar ataxia (SCA) is inherited neurodegenera-
tive disorders in associated with progressive cerebellar
degeneration affecting worldwide populations. Causative
genetic defects underlying SCA are extensively heteroge-
neous, which types and prevalence of SCA are widely
varied among different populations. In Thailand, almost
90 % of familial SCA families, and over 30 % of sporadic
cases are Machado-Joseph disease (MJD, or SCA3), SCA1,
SCA2 and SCA6 [1]. In contrast, SCA7 and dentatorubro-
pallidoluysian atrophy (DRPLA) have not been observed
to date. Since some other uncommon types of SCA
have been described in multiple ethnics, those certain
types are merit for further screening in the Thai pa-
tients [2]. The study was interested in investigating
some uncommon SCAs including SCA8, SCA10, SCA12,
SCA17 and SCA19.
SCA8 is caused by bidirectional transcribed of CTG-
CAG repeat-expansion mutation of ataxin 8 opposite
strand (ATXN8OS), and ataxin 8 (ATXN8) on chromo-
some 13q21 [3]. The disease is transmitted in autosomal
dominant fashion with often reduced penetrance [4].
Patients present as a slowly progressive cerebellar syn-
drome frequently accompanied with pyramidal signs
[4, 5]. SCA10 is an autosomal dominant ataxia often
accompanied with epilepsy caused by an expansion of a
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pentanucleotide (ATTCT) repeat in intron 9 of ATXN10.
The disease is exclusively identified in Amerindian de-
scents mainly in South America, in which they are likely
to share a common ancestral origin [6, 7]. SCA12 is
caused by a CAG repeat expansion in a promoter region
of the PPP2R2B on chromosome 5q32 [8]. Action tremor
is often a prominent feature. Apart from Caucasians,
SCA12 is also identified as an infrequent cause of SCA in
Indians and Chinese [9–11]. SCA17 is caused by an ab-
normal CAG/CAA repeat expansion in TATA-binding
protein gene (TBP) [12]. Various additional features in-
cluding parkinsonism, chorea, dystonia and dementia is
common. Although SCA17 regards as an uncommon type
of SCA, the disease is described in quite a few populations
including in East Asian [13, 14]. Furthermore, the patho-
logical repeat-expansion alleles of SCA17 were also ob-
served in association with Parkinson’s disease (PD) in
Taiwanese and Korean, implying the occurrence of SCA17
might be relatively common in East Asian [15, 16]. SCA19
and SCA22 were originally described in Dutch and Han
Chinese families, respectively. Both diseases were mapped
to the same locus on chromosome 1q [17]. Their pheno-
types were similar in some extents, which they often
present as a very slowly progressive ataxia with fre-
quent hyporeflexia. However, additional features in-
cluding Holmes tremor, myoclonus and impairment of
proprioceptive sensation were only observed in some
cases of the Dutch family [18, 19]. Recently, a voltage-
gated potassium channel Kv4.3-encoding gene (KCND3)
was described as a causative gene responsible for both
SCA19 and SCA22 [20, 21].
The study attempted to identify the SCA subtypes in
Thai patients without any known genetic mutations, and
defined their genotype-phenotype correlations. SCA8,
SCA12, SCA17, and SCA19/22 were designated to ana-
lyse because they were described in multiple popula-
tions. Since a few of the studied patients had epilepsy as
an additional feature, SCA10 was designated to investi-
gate as a candidate gene.
Methods
Participants and DNA samples
We studied on all collected DNA samples of patients with
progressive cerebellar degeneration, in which genetic tests
for SCA1, SCA2, MJD, SCA6, SCA7 and DRPLA were
negative. The studied patients were also carefully investi-
gated to exclude other possible diagnoses including auto-
immune cerebellar disorders, cerebellar variant of multiple
system atrophy, and common mitochondrial DNA muta-
tions by using appropriated blood tests, genetic analysis of
leukocyte, or muscle DNA and neuroimaging. DNA sam-
ples of 82 index patients were available for eventually
complete all genetic analyses in the study. All obtainable
medical records of the participants were reviewed.
Accessible patients were also re-examined. Control sub-
jects were individuals aged over 65 years old without signs
of any movement disorders. The control DNA samples
were previously obtained for previous study on Parkinson
genetics during 2008 to 2013 [22].
Ethics, consent and permissions
The research protocol was approved by the ethics com-
mittee of the Ramathibodi Hospital, Mahidol University
(ID 03-53-19). All participants were provided appropriate
genetic counselling and informed consent prior taking
their blood samples.
Genetic analysis
Size of repeat expansion DNA samples were extracted
from peripheral leukocyte by phenol-chloroform method
or using QIAGEN DNA purification kit (QIAGEN, CA,
USA). Fluorescent PCR of the tandem repeat alleles of
the ATXN8OS (SCA8), PPP2R2B (SCA12) and TBP
(SCA17) were undertaken by using methods kindly pro-
vided by Neurogenetics Lab, UCL Institute of Neurology,
London. The PCR amplicons were checked on agarose
gel. The allele sizes were then determined by capillary
electrophoresis on the 3730XL DNA Analyzer (Applied
Biosystems, CA, USA). PCR fragments were analysed by
using Peak Scanner V.1 (Applied Biosystems, CA, USA).
Sizes of tandem repeat of both normal and pathological
alleles of each chromosome were calculated by comparing
results with the size of normal control samples, of which
the sizes were prior defined by direct sequencing. Sizes of
normal alleles in Thai individuals were determined by
analysis in 80 controls for SCA8 and SCA12 alleles, and
374 control subjects for SCA17 allele. Identification of
normal and abnormal repeat expansion alleles for each
SCA subtypes were established by using data of previ-
ous reports, which they were considered as the follow-
ing circumstances: normal SCA8 allele ranged from 15
to 50 repeats [23]; normal SCA12 allele ranged from 4
to 32 repeats [24]; and pathological SCA17 alleles
were ≥ 42 repeats [16].
Fluorescent repeat-primed PCR assay
ATXN10 (SCA10) was screened by fluorescent repeat-
primed PCR assay [25]. SCA10 is associated with a huge,
several hundred of pentanucleotide repeats, while sizes
of normal alleles are generally very short with upper
limit of 33 repeats. Under this circumstance, fluorescent
repeat-primed PCR amplification is a simple screening
method, which is able to distinguish a normal short
tandem repeats from potentially pathological SCA10 ex-
pansion alleles [25]. Electrophoresis was run on the
3730XL DNA Analyzer, and analysis of the PCR frag-
ments were determined using Peak Scanner V.1.
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Sequencing analysis
All 8 exons and exon-intron boundaries of KCND3
(NT019273; NM004980) were directly sequenced on
both strands in all patients by using the Big Dye Termin-
ator Cycle Sequencing kit (Applied Biosystems, CA,
USA). Primer sets and PCR conditions (shown in
Additional file 1: Table S1) were newly designed accord-
ing to the standard KCND3 sequence [26]. The PCR
products were then loaded into the 3730XL DNA
Analyzer and analysed with the Sequence Analysis soft-
ware v3.0 (Applied Biosystems, CA, USA).
Statistical analysis
Results were expressed as means ± standard deviations.
Correlation between trinucleotide repeat lengths and age
at onset were determined by linear regression model.
The p-value associated with the correlation coefficient
(r) was calculated on the basis of two-tailed probabilities.
P less than 0.05 was considered to be statistical signifi-
cant. Analysis was performed on VassarStats website for
statistical computation (http://www.vassarstats.net).
Results
The study identified only SCA17 mutation in this panel
of 82 unrelated Thai patients with cerebellar degener-
ation of unknown origin. There were eight patients hav-
ing ≥ 42 trinucleotide repeat alleles in the TBP. Five of
these eight patients had complete medical records, and
four patients were also re-examined. Available clinical
details of the SCA17 patients are shown in Table 1. Only
one patient had family history compatible with auto-
somal dominant inheritance, while the rest of the pa-
tients were sporadic. However, we did not examine
parents and other family members of those patients.
Phenotypes were quite variable including (1) spinocere-
bellar ataxia accompanied with prominent parkinsonism;
(2) spinocerebellar ataxia accompanied with generalized
chorea, dystonia and myoclonus; (3) relatively pure cere-
bellar syndrome. Dementia was common feature in asso-
ciation with all cases. Gazed-evoked nystagmus, broken
pursuit and saccadic abnormalities also sometimes ob-
served. Mean age at onset was 34.4 ± 16.1 years (range
18–67 years). Age at onset was relatively earlier in the
patients carrying over 50 repeat alleles than in the pa-
tients carried smaller pathological alleles. Linear regres-
sion analysis demonstrated a reverse correlation between
the sizes of trinucleotide repeats and age at onset with the
correlation coefficient (r) of −0.84 [r2 = 0.71; p = 0.017,
95 % confidence interval = (−0.98) - (−0.25)]. The regres-
sion line suggested that an expected age at onset was
decreased for an interval of 2.173 years on the basis
of one repeat expansion changed. Nevertheless, this
formula could not predict an accurate age at onset
for each particular patient.
Cognitive impairment was the most common add-
itional feature identified in most patients examined.
Three out of four examined patients had dementia and
one had mild cognitive impairment involving both ex-
ecutive and memory functions. The other patient (no.
39.3) did not have an adequate cognitive assessment in
her medical record. The three remaining patients were
lost to follow up; they were only known to have pro-
gressive cerebellar degeneration with ataxia. Cognitive
impairment developed even only a few years after the
onset, which it could progress to severe dementia at
very young age. Similar to previous reports, parkinson-
ism, dystonia and chorea were additional non-ataxic
features observed in SCA17 patients.
Association between a heterozygous 41-repeat allele of
TBP (SCA17) and phenotypic expression has remained
unclear. Therefore the study presented the actual observa-
tions related to the carriers of the TBP 41-repeat allele
Table 1 Clinical details of SCA17 patients
Patient No. Age at onset (years) Duration (years) Gender Family history Severity
of ataxia
Additional features Pathological CAG/CAA
repeat length
32 24 2 M no severe parkinsonism, foot dystonia,
pyramidal signs, dementia
54
47 26 9 M no severe parkinsonism, dementia 54
19.1 na na M na na na 43
39.3 40 1 F no mild nonea 42
128 36 12 M AD severe generalized chorea, limb
dystonia, myoclonus, dementia
45
154 30 4 F no moderate na 52
179 18 2 M no moderate na 57
259 67 7 F no mild neck tremor, mild cognitive
impairment
42
M male, F female, AD autosomal dominant, na not available
aThe patient was not assessed by adequate cognitive evaluation
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without a definite conclusion. Mean of the tandem repeat
sizes of TBP in 374 control subjects was 37.12 ± 3.12 re-
peats (mode = 36; median = 36) (Fig. 1). Only one
female patient carried a heterozygous 41 repeats (allele
frequency = 0.006), whereas eight control subjects (allele
frequency = 0.01) did. The 29-year-old female patient has
developed progressive ataxia for one year. Her phenotype
was pure cerebellar ataxia. She had no family of any
movement disorders. The other carriers of the 41-repeat
allele (control group) aged from 66 to 81 years old (mean
74 ± 4.5 years). Two of these controls were unable to be
contacted, and one of them was deceased. Thus, we re-
examined five out of the eight carriers. Examination re-
vealed no cerebellar signs in all carriers. However, three of
them had mild, but definite signs of parkinsonism with
typical rest tremor in one carrier. Two of these patients
also had significant cognitive impairment [Montreal Cog-
nitive Assessment (MoCA) = 13 and 18]. One of the car-
riers without parkinsonism, a 66-year-old female, had
mild cognitive impairment (MoCA = 23). The remaining
patient was in terminal stage of cirrhosis without any signs
of parkinsonism.
Genetic analyses for SCA8, SCA10, SCA12 and
SCA19/22 were all unremarkable. Mean of the tandem
repeat sizes of ATXN8OS (SCA8) was 23.07 ± 3.94 repeats
(mode = 18; range = 18–32 repeats), and mean of the tan-
dem repeat sizes of PPP2R2B (SCA12) was 13.14 ± 2.60
repeats (mode = 10; range = 9–24 repeats). Sequencing of
KCND3 in all of the patients was identified only heterozy-
gous single nucleotide polymorphisms including one
newly identified silent variant in exon 2 (p.Pro88Pro), one
known silent variant (p.Pro125Pro; rs2289723), and three
intron variants (rs369047161, rs72548727 and rs640029).
Discussion
Spinocerebellar ataxias are widely heterogeneous neuro-
degenerative disorders, which definitive diagnosis is
often required DNA analysis using various specific gen-
etic testings. To set-up the optimal genetic tests for cer-
tain population are often needed to rely on its own
epidemiological data. Information regarding subtypes of
SCA in Thai population has still limited. Analysis of the
common SCA subtypes revealed that about 50 % of the
patients were MJD, SCA1, SCA2 and SCA6 [1]. In an ef-
fort to further describe the specific SCA genotypes in
the remaining patients without any known cause, the
study identified that about 10 % of these patients carried
SCA17 mutation. Whilst SCA8, SCA10, SCA12 and
SCA19 were absent in the study implying that they ap-
pear to be rare in Thai population.
SCA17 is relatively uncommon, despite its worldwide
distribution. For instance, SCA17 accounted for only 1 %
of the SCA patients in a large Caucasian cohort [27]. Most
reports described only single, or a few families. To date,
less than 100 families have been described [28]. This study
cohort was originally consisted of 265 families with ataxia
Fig. 1 Frequency distribution of CAG/CAA repeat lengths in ataxia and healthy control groups
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[1]. About half of those SCA families were unable to de-
termine cause. Although only 82 DNA samples (63 % of
the remaining patients with unknown cause) were avail-
able for the study, the authors identified 8 unrelated pa-
tients (~10 %) carried CAG/CAA expansion of the TBP
gene. This data suggests that SCA17 is an important cause
of adult-onset progressive ataxia in Thais especially coex-
isted with dementia, parkinsonism and chorea, despite
sporadic nature.
Phenotype of SCA17 is often variable. It frequently ac-
companies with dementia and other abnormal movements
including parkinsonism, chorea, dystonia and myoclonus
[12, 27, 29–31]. Phenotypes of Thai SCA17 patients in the
study were similar to those prior described in Caucasians
and Japanese. Since the previous work in the large Thai
cohort demonstrated that all these features particularly
abnormal movements were extremely uncommon in asso-
ciation with MJD, SCA1, SCA2, and SCA6 [1]. Those
signs especially parkinsonism and dementia is quite useful
for helping on differential diagnosis between SCA17 and
those common SCAs in Thais.
Sizes of the SCA17 triplet repeat appear to have cor-
relate to some clinical expressions. SCA17 can also exhibit
Huntington’s disease-like (HDL) phenotype [30, 32]. The
phenotype is often observed in association with a mode-
rately small pathological repeat size, or generally less than
50 repeats. Likewise, the only studied case (No. 128) hav-
ing generalized chorea and dementia resembling HDL
had the repeat size of 45, and none of the patients car-
ried the repeat size greater than 50 developed chorea.
Furthermore, the study observed the significant inverse
correlation between the sizes of CAG/CAA repeat and
age at onset of the disease. The repeat expansion greater
than 50 often associated with an early age at onset before
30 years. The latest age at onset was 67 in a female patient
(No.259) carried a 42-repeat allele. This observed correl-
ation is in line with some previous reports [27].
Parkinsonism and dementia is one of the most common
non-ataxic features in association with SCA17. Moreover,
the repeat expansions of SCA17 were formerly detected
in a small proportion of patients with PD [15]. Those
patients often carried a relatively small SCA17 patho-
logical alleles (43–46 repeats). Even asymptomatic car-
riers of the 42-repeat allele had decreased striatal DAT
binding implying that the expansion as low as 42 re-
peats might contribute to develop parkinsonism [16].
In the study, one female patient, and eight of the con-
trol subjects carried the 41-repeat SCA17 allele. Al-
though ataxia was not observed in the control subjects,
parkinsonism and cognitive impairment was clearly evi-
dent in almost all control subjects after re-examined.
To our knowledge, there were two earlier case reports
of SCA17 associated with the 41-repeat allele [33, 34].
Our data together with the others suggest that the 41
CAG/CAA repeat of the SCA17 gene may not be a
neutral polymorphisms, but it likely contributes to a
wide range of neurodegeneration of the striatal, cogni-
tive and cerebellar pathway.
Most of the studied SCA17 patients were sporadic
cases. The lack of family history in the study may ex-
plain by several factors. Firstly, it was a retrospective
study; some important information might be missing.
Alternatively, the patients’ parents might remain asymp-
tomatic due to anticipation [35]. Or, it might cause by
that SCA17 was transmitted by an autosomal dominant
fashion with reduce penetrance [12, 29, 30].
Conclusion
In summary, the study demonstrates that SCA17 is an
important cause of adult-onset spinocerebellar ataxia in
Thailand. In contrast, SCA8, SCA10, SCA12, and SCA19
are rare. Parkinsonism and cognitive impairment are use-
ful for clinically distinguishing between SCA17 and other
common SCA subtypes in Thai patients. Although the
cut-off point of the pathological CAG/CAA expansion of
the SCA17 gene remains unclear, the study provides evi-
dence that the 41 repeat allele is likely to contribute some
pathogenic effect. Carriers of the 41 repeat of the SCA17
gene may need a long-termed follow up.
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